Tacrolimus therapy in primary Sj ögren's syndrome with refractory immune thrombocytopenia: a retrospective study

CONCLUSIONS: TAC is effective and well tolerated by pSS patients with RITP, and the mechanism underlying the effect of TAC in these patients may be related to reduced Th1 cytokine expression.PMID:36135951 | DOI:10.55563/clinexprheumatol/5c7l01

Source: Clinical and Experimental Rheumatology - September 22, 2022 Category: Rheumatology Authors: Rong Xu Qing Yan Yan Gong Cheng-Sen Cai Jian Wu Xin-Yu Yuan Xian-Ming Long Source Type: research